Succinimide

Succinimide

SCHEMBL28044128

O=C1CCC(=O)N1.O=CO

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 5/20 0.69
NPC1 O15118 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
ITGB3 P05106 1/20 0.33
ITGB1 P05556 1/20 0.33
ITGAV P06756 1/20 0.33
ITGA4 P13612 1/20 0.33
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinimide SCHEMBL28922106 0.89 CRBN (0.55) CRBNNPC1MAPK13MAPK12MAPK11
Formic Acid SCHEMBL29113973 0.88 CRBN (0.72) CRBNITGB3ITGB1ITGAVITGA4
Formic Acid SCHEMBL30727529 0.88 CRBN (0.72) CRBNITGB3ITGB1ITGAVITGA4
Succinimide SCHEMBL1600526 0.83
Succinimide SCHEMBL1326078 0.83 CRBN (1.00) CRBNNPC1MAPK13MAPK12MAPK11
Succinimide SCHEMBL774 0.83
Succinimide SCHEMBL1466558 0.83
Succinimide SCHEMBL8361206 0.83 CRBN (1.00) CRBNNPC1MAPK13MAPK12MAPK11
Succinimide SCHEMBL10709037 0.79
Succinimide SCHEMBL9336599 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4288442-A1 UBIQUITIN-SPECIFIC PROTEASE 7 (USP7) INHIBITORS AND USES THEREOF Faxian Therapeutics, LLC (US) 2023-12-13 EP disclosed
WO-2022170198-A1 UBIQUITIN-SPECIFIC PROTEASE 7 (USP7) INHIBITORS AND USES THEREOF FAXIAN THERAPEUTICS, LLC (US) 2022-08-11 WO disclosed
CN-105189504-B Fused tetracyclic bromodomain inhibitors 艾伯维公司 2017-07-18 CN disclosed
CN-105189504-A Fused tetracyclic bromodomain inhibitors ABBVIE INC 2015-12-23 CN disclosed